Last updated 2026-07-20
- Raised $7.1M Series A led by Lightspeed Venture Partners, Dec 2024
- Raised Seed round led by Lightspeed Venture Partners, Oct 2023
- Raised grant, Sep 2021
Total raised
$7.1M
Last: Undisclosed Round 2025-01
Stage
Seed
Founded
2020
Headcount
20
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Senseera is a biotechnology company that is revolutionizing precision medicine through its proprietary cfChIP-seq liquid biopsy platform. The company's platform decodes cell-specific gene expression and cell states from blood samples, providing detailed molecular insights for diagnosing and monitoring diseases. Senseera focuses on liver diagnostics, aiming to provide earlier, safer, and more accurate disease detection. They also collaborate with pharmaceutical companies to unlock insights in oncology, immunology, and toxicity, supporting drug development and personalized treatments. Senseera's GEM BIOMARKERS™ platform is built on decades of research led by Prof. Nir Friedman and validated in top-tier journals such as Nature Biotechnology. The company has a unique atlas of over 20,000 annotated human samples.
Funding history · 3 rounds · $7.1M total
2024-12
A Round
$7.1M
★ Lightspeed Venture PartnersI-NEXT CapitalLowy Medical Research Institute
2023-10
Seed
Undisclosed
★ Lightspeed Venture Partners
2021-09
Grant
Undisclosed
Headcount over time
From 4 (2021-02) to 19 (2026-03) · +15 (+375%) · 15 points · source: Finder history + radar grounding
Q&A
- What is Senseera Health's primary focus?
- Senseera Health is focused on developing a new generation of liquid biopsy blood tests to provide information about disease processes in internal organs and the immune system. Their initial product line aims for early detection and monitoring of cancer.
- When was Senseera Health founded?
- Senseera Health was founded in August 2020.
- How many employees does Senseera Health have?
- Senseera Health has between 11-50 employees.
- What is Senseera Health's total funding to date?
- Senseera Health has raised a total of $7,100,000.
- Which investors participated in Senseera Health's January 2025 funding round?
- In January 2025, Senseera Health raised $7,100,000 from investors including.
- What technology does Senseera Health utilize?
- Senseera Health uses molecular biology, next-generation sequencing, and advanced computational analysis to extract epigenetic information from chromatin fragments in the blood, employing its cfChIP-seq technology.
- Who are the co-founders of Senseera Health?
- The co-founders of Senseera Health are Ronen Sadeh (Co-founder & CEO), Nir Friedman (Co-founder), Jenia Gutin (Co-founder & CTO), and Israa Sharkia (Co-founder & VP R&D).
- What is the current product stage of Senseera Health?
- Senseera Health's product is currently in the clinical trial stage.
Team · 4
Nir Friedman
Founder · Co-Founder
Jenia Gutin
Founder · Co-Founder and CTO
Israa Sharkia
Founder · Co-Founder and VP R&D
Ronen Sadeh
Founder · Co-Founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcareLaboratories
Business model
B2B
Tags
disease-managementmolecular-biologylaboratoriesearly-detectiondigital-healthcarebiotechnologymonitoringblood-testcancerdiagnostics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | senseerahealth.com |
|---|---|
| linkedin.com/company/75502239 |
Identifiers & details
| Founded | 2020-8 |
|---|---|
| Employees (exact) | 20 |
Radar intelligence
Web history (Wayback)
| Domain | senseerahealth.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516240769 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2020-08-19 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 2 — violation (1), people (1) |
| Registered address | פרופ רקח 3.3 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |
| 2026-03-11 | עדכון דירקטורים-הסרת דירקטור |